← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Kovina Therapeutics Inc.
Indianapolis, IN
$2,904,967
Total funding
4
Grants
Funding over time
peak $1M · FY2022–24$2M$1.5M$1M$500K$0
'22
'23
'24
Funding mix
By agency
NIH$2,904,967 · 4
By mechanism
R44$1,909,685 · 1
R43$574,293 · 2
R42$420,989 · 1
Investigators at Kovina Therapeutics Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
From Academia to Business: Development of Novel Therapeutics Against HPV-Associated Cancer$1,000,028
R44 · FY2024 · CA
From Academia to Business: Development of Novel Therapeutics Against HPV-Associated Cancer$909,657
R44 · FY2023 · CA
From Academia to Business: Development of Novel Therapeutics Against HPV-Associated Cancer$420,989
R42 · FY2022 · CA
Small Molecule E6 Inhibitors to Treat Dysplasia Caused by HPV Infections$298,527
R43 · FY2022 · AI
Small Molecule E6 Inhibitors to Treat Oropharyngeal Cancers Caused by HPV Infections$275,766
R43 · FY2022 · DE